MedPath

A prospective observational study of comparison between radical prostatectomy and radiation therapy for high risk prostate cancer

Not Applicable
Recruiting
Conditions
prostate cancer
Registration Number
JPRN-UMIN000033343
Lead Sponsor
Saitama Medical University International Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who were not tested for high-risk prostate cancer or were found to have metastatic prostate cancer as a result of further testing (however, data and samples up to that point are used for preliminary analysis).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood / urinalysis, physical findings, tumor assessment of prostate and pelvic lymph nodes (non-contrast MRI) are performed every 3 months.
Secondary Outcome Measures
NameTimeMethod
Evaluation of complications (international prostate symptom score IPSS (6)), quality of life after surgery (EuroQol 5 Dimension; EQ - 5D (7) and FACT - P (8)) and erectile function (International erectile function score; Evaluation of IIEF 5 (9)) every 3 months.
© Copyright 2025. All Rights Reserved by MedPath